
Chartanalyse Cooper Companies: Qualitätsaktie im Aufwind
Die Aktie bietet mittelfristig fast 30 % Potenzial.
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Die Aktie bietet mittelfristig fast 30 % Potenzial.
Cooper Companies stock hits 52-week low at $84.49
The headline numbers for The Cooper Companies (COO) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some...
The Cooper Companies (COO) delivered earnings and revenue surprises of 0% and 1.71%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies...
Lowes (LOW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.